Your Daily Brief For May 3rd

Your Daily Brief For May 3rd

10 months ago1 min

Mentioned in story

Today's Stories

Today's Insight

Your Brief Summary

In today’s Daily Brief, we'll be looking at Pfizer, which just released its latest quarterly results.

"Pfizer's sales of Covid products continued to plunge last quarter – but things weren't as bad as analysts were expecting, so the drugmaker still bested expectations."

Key takeaways:

  • Pfizer’s sales slipped but it still managed to outpace expectations
  • JPMorgan took First Republic Bank off regulators’ hands this week
Finimize

BECOME A SMARTER INVESTOR

All the daily investing news and insights you need in one subscription.

Disclaimer: These articles are provided for information purposes only. Occasionally, an opinion about whether to buy or sell a specific investment may be provided. The content is not intended to be a personal recommendation to buy or sell any financial instrument or product, or to adopt any investment strategy as it is not provided based on an assessment of your investing knowledge and experience, your financial situation or your investment objectives. The value of your investments, and the income derived from them, may go down as well as up. You may not get back all the money that you invest. The investments referred to in this article may not be suitable for all investors, and if in doubt, an investor should seek advice from a qualified investment advisor.

/3 Your free quarterly content is about to expire. Uncover the biggest trends and opportunities. Subscribe now for 50%. Cancel anytime.

Finimize
© Finimize Ltd. 2023. 10328011. 280 Bishopsgate, London, EC2M 4AG